Administration of Vaginal and Rectal Progesterone During FET Cycles

Thor Haahr277 enrolled

Overview

Observational study of reproductive outcome after frozen embryo transfer in HRT with vaginal and rectal progesterone.

Cohort of patients treated with autologous blastocyst at the Fertility clinic Skive Regional Hospital in HRT cycle. Estradiol stimulation started on second cycle day and on day 12 - 20 vaginal and rectal progesterone is added. Blastocyst transfer on 6th progesterone treatment day. Serum progesterone and hCG measurement 9 or 11 days after embryo transfer.

Study Type

OBSERVATIONAL

Enrollment

277

Conditions

Infertility

Interventions

ProgesteroneDRUG

6 mg estradiol and vaginal and rectal progesterone

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Frozen embryo transfer cycles in HRT cycles Exclusion Criteria: * Donor frozen embryo transfer

Locations (1)

Fertility Clinic Regional Hospital Skive

Skive, Denmark

Outcomes

Primary Outcomes

ongoing pregnancy

gestational week 12

Time frame: 4 month

Secondary Outcomes

pregnancy rate

positive hCG

Time frame: 4 month

Pregnancy loss

pregnancy loss before week 7

Time frame: 4 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.